Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 669Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Rosuzet

PharmaCompass

01

Brand Name : Rosuzet

Ezetimibe/Rosuvastatin

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Rosuzet

arrow
2024 ACI Convention
Not Confirmed

Ezetimibe/Rosuvastatin

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2021 Revenue in Millions : 68

2020 Revenue in Millions : 130

Growth (%) : -48

blank

02

Brand Name : Rosuzet

Rosuvastatin

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Rosuzet

arrow
2024 ACI Convention
Not Confirmed

Rosuvastatin

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2022 Revenue in Millions : 71

2021 Revenue in Millions : 68

Growth (%) : 4

blank

03

Brand Name : Rosuzet

Rosuvastatin

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Rosuzet

arrow
2024 ACI Convention
Not Confirmed

Rosuvastatin

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2023 Revenue in Millions : 70

2022 Revenue in Millions : 71

Growth (%) : -1

blank